WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt
BSE579.459.2 (+1.61 %)
PREV CLOSE ( ) 570.25
OPEN PRICE ( ) 578.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 30320
TODAY'S LOW / HIGH ( )567.00 594.00
52 WK LOW / HIGH ( )166.3 630
NSE573.753.1 (+0.54 %)
PREV CLOSE( ) 570.65
OPEN PRICE ( ) 576.00
BID PRICE (QTY) 573.75 (208)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 440684
TODAY'S LOW / HIGH( ) 565.00 595.00
52 WK LOW / HIGH ( )166.25 630
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax-6240.00-4110.009160.00-1966.80-3003.20
Adjustment6350.005540.00-9430.004832.304445.20
Changes In working Capital1530.003670.00-1430.003795.80802.90
Cash Flow after changes in Working Capital1640.005100.00-1700.006661.302244.90
Cash Flow from Operating Activities1530.004130.00-2870.006489.601833.20
Cash Flow from Investing Activities-1250.00-2010.0014700.00-1555.30945.70
Cash Flow from Financing Activities-3150.00-710.00-11710.00-6795.80-7764.50
Net Cash Inflow / Outflow-2870.001410.00120.00-1861.50-4985.60
Opening Cash & Cash Equivalents3700.002320.002190.003973.408972.40
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations70.00-30.0010.0081.50-13.40
Closing Cash & Cash Equivalent900.003700.002320.002193.403973.40

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.